A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients

A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients

Background: Pterygium is an ocular surface disorder with prevalence rates ranges from 0.3% to 29% in different parts of the world. Vascular endothelial growth factor (VEGF) has been detected in increased amounts in pterygium epithelium, compared with normal conjunctiva. Bevacizumab is a recombinant,...

Full description

Bibliographic Details
Main Authors: Priyanka Singh, Lopa Sarkar, H S Sethi, V S Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Bevacizumab
pterygium
subconjuctival
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2015;volume=63;issue=10;spage=779;epage=784;aulast=Singh

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2015;volume=63;issue=10;spage=779;epage=784;aulast=Singh

Similar Items